On Friday 03/17/2023 the closing price of the Walgreens Boots Alliance Inc share was $32.91 on NAS.
Compared to the opening price on Friday 03/17/2023 on NAS of $33.18, this is a drop of 0.82%.
Walgreens Boots Alliance Inc's market capitalization is $28.94 B by 862.50 M shares outstanding.
Is Walgreens Boots Alliance stock a Buy, Sell or Hold?
Walgreens Boots Alliance stock has received a consensus rating of hold. The average rating score is and is based on 3 buy ratings, 26 hold ratings, and 5 sell ratings.What was the 52-week low for Walgreens Boots Alliance stock?
The low in the last 52 weeks of Walgreens Boots Alliance stock was 30.39. According to the current price, Walgreens Boots Alliance is 108.29% away from the 52-week low.What was the 52-week high for Walgreens Boots Alliance stock?
The high in the last 52 weeks of Walgreens Boots Alliance stock was 48.61. According to the current price, Walgreens Boots Alliance is 67.70% away from the 52-week high.What are analysts forecasts for Walgreens Boots Alliance stock?
The 34 analysts offering price forecasts for Walgreens Boots Alliance have a median target of 44.68, with a high estimate of 60.00 and a low estimate of 32.00. The median estimate represents a 73.66 difference from the last price of 32.91.Walgreens Boots Alliance Stock Snapshot
32.92
Bid
26,800.00
Bid Size
32.94
Ask
69,500.00
Ask Size
3/17/2023
Date
8:00 PM
Time
10.25 M
Volume
33.41
Prev. Close
33.18
Open
28.94 B
Market Cap
862.50 M
Number of Shares
32.54
Day Low
33.33
Day High
32.91
30.39
52 Week Low
48.61
52 Week High
32.91
1.97
Dividend
5.91
Dividend Yield
6.98
P/E Ratio
82.71
Free Float in %
4.51
EPS 2023
27.70
Book Value per Share
4.96
Cash Flow per Share
Walgreens Boots Alliance News More News
Walgreens Boots Alliance Historical Prices
| Date | Open | Close | Daily High | Daily Low |
|---|
Price change over selected period:
0%
0
Walgreens Boots Alliance Analyst Data
Total Analysts: 34
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 32.00
Median: 44.68
Highest: 60.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Walgreens Boots Alliance Analyst Opinions
- All
- Buy
- Hold
- Sell
| 02/23/23 | Loop Capital | Maintained Buy | $45 | ||
| 01/30/23 | Morgan Stanley | Maintained Sell | $37 | ||
| 01/06/23 | J.P. Morgan | Maintained Hold | $40 | ||
| 01/06/23 | Credit Suisse | Maintained Hold | $41 | ||
| 12/14/22 | Mizuho | Maintained Hold | $41 | ||
| 11/22/22 | Cowen and Company, LLC | Upgraded to Buy | $54 | ||
| 11/18/22 | J.P. Morgan | Upgraded to Buy | |||
| 11/11/22 | Deutsche Bank | Upgraded to Buy | $50 | ||
| 10/25/22 | Deutsche Bank | Maintained Hold | $41 | ||
| 10/19/22 | RBC Capital Markets | Maintained Hold | $36 | ||
| 10/14/22 | Credit Suisse | Maintained Hold | $42 | ||
| 10/07/22 | Mizuho | Maintained Hold | $36 | ||
| 10/07/22 | UBS | Maintained Hold | $37 | ||
| 10/03/22 | Evercore | Maintained Hold | $32 | ||
| 09/22/22 | Deutsche Bank | Maintained Hold | $38 | ||
| 07/08/22 | J.P. Morgan | Maintained Hold | $45 | ||
| 07/06/22 | Morgan Stanley | Maintained Sell | $39 | ||
| 07/05/22 | RBC Capital Markets | Maintained Hold | $42 | ||
| 07/01/22 | Deutsche Bank | Maintained Hold | $44 | ||
| 07/01/22 | Credit Suisse | Maintained Hold | $43 | ||
| 06/27/22 | Barclays Capital | Maintained Hold | $45 | ||
| 06/06/22 | Morgan Stanley | Maintained Sell | $43 | ||
| 06/02/22 | Morgan Stanley | Maintained Sell | $43 | ||
| 04/05/22 | Deutsche Bank | Maintained Hold | $46 | ||
| 04/05/22 | UBS | Maintained Hold | $49 | ||
| 04/01/22 | Barclays Capital | Maintained Hold | $50 | ||
| 04/01/22 | RBC Capital Markets | Maintained Hold | $46 | ||
| 04/01/22 | Baird Patrick & Co | Downgraded to Hold | $51 | ||
| 12/22/21 | UBS | Maintained Hold | $52 | ||
| 12/16/21 | Morgan Stanley | Downgraded to Sell | $49 | ||
| 10/25/21 | Credit Suisse | Maintained Hold | $52 | ||
| 07/02/21 | Credit Suisse | Maintained Hold | $48 | ||
| 04/14/21 | Morgan Stanley | Maintained Hold | $60 | ||
| 04/01/21 | Credit Suisse | Maintained Hold | $50 | ||
| 03/30/21 | Morgan Stanley | Maintained Hold | $52 |
Walgreens Boots Alliance Estimates* in USD
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
| Revenue | 135,263 | 142,135 | 148,871 | 155,019 | 172,276 |
| Dividend | 1.97 | 2.03 | 2.08 | - | - |
| Dividend Yield (in %) | 5.91 % | 6.09 % | 6.24 % | - | - |
| EPS | 4.51 | 4.83 | 5.35 | 6.06 | 6.94 |
| P/E Ratio | 7.24 | 6.76 | 6.10 | 5.38 | 4.70 |
| EBIT | 4,866 | 5,368 | 5,915 | 6,766 | 7,658 |
| EBITDA | - | 6,586 | 7,289 | - | - |
| Net Profit | 3,878 | 4,144 | 4,552 | 5,047 | 5,599 |
| Net Profit Adjusted | 3,878 | 4,144 | 4,552 | 5,047 | 5,599 |
| Pre-Tax Profit | 4,175 | 4,817 | 5,339 | 6,388 | 7,303 |
| Net Profit (Adjusted) | -2,655 | 4,008 | 4,435 | - | - |
| EPS (Non-GAAP) ex. SOE | 4.52 | 4.66 | 4.90 | 6.06 | 6.94 |
| EPS (GAAP) | -1.33 | 3.47 | 4.28 | 5.39 | 6.25 |
| Gross Income | 28,427 | 29,478 | 31,396 | 35,529 | 37,824 |
| Cash Flow from Investing | -2,075 | -1,545 | - | - | - |
| Cash Flow from Operations | 3,768 | 5,481 | 7,094 | 7,801 | 8,518 |
| Cash Flow from Financing | 82 | -2,061 | -500 | -500 | - |
| Cash Flow per Share | 4.96 | 6.06 | 7.08 | - | - |
| Free Cash Flow | 2,188 | 3,967 | 5,086 | 5,693 | 6,305 |
| Free Cash Flow per Share | 3.73 | 4.27 | - | - | - |
| Book Value per Share | 27.70 | 29.52 | 32.84 | - | - |
| Net Debt | 12,259 | 10,295 | 9,536 | - | - |
| Research & Development Exp. | - | - | - | - | - |
| Capital Expenditure | 1,792 | 1,828 | 2,068 | 2,108 | 2,213 |
| Selling, General & Admin. Exp. | 26,971 | 24,948 | 27,099 | 29,267 | 30,714 |
| Shareholder’s Equity | 25,712 | 27,276 | 29,567 | 32,799 | 34,390 |
| Total Assets | 92,487 | 94,176 | 103,343 | 106,791 | 110,274 |
| Previous Quarter |
Current Quarter ending 02/28/23 |
Next Quarter ending 05/31/23 |
Current Year ending 08/31/23 |
Next Year ending 08/31/24 |
|
|---|---|---|---|---|---|
| Earnings Estimates | |||||
| No. of Analysts | - | 15 | 15 | 17 | 17 |
| Average Estimate | - | 1.101 USD | 1.122 USD | 4.508 USD | 4.829 USD |
| Year Ago | - | 1.590 USD | 0.960 USD | 5.040 USD | 4.508 USD |
| Publish Date | - | 1/5/2023 | 3/28/2023 | - | - |
| Revenue Estimates | |||||
| No. of Analysts | - | 12 | 11 | 14 | 13 |
| Average Estimate | - | 33,412 USD | 33,888 USD | 135,263 USD | 142,135 USD |
| Year Ago | - | 33,756 USD | 32,597 USD | 132,703 USD | 135,263 USD |
| Publish Date | - | 1/5/2023 | 3/28/2023 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Walgreens Boots Alliance Insider Activity
| Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
|---|---|---|---|---|---|---|
| BREWER ROSALIND G | 03/14/2023 | 25,301.00 | 359,945.00 | 33.29 | Sell | No |
| Ban Kevin M. | 11/17/2022 | 10,303.00 | 27,916.00 | 40.19 | Sell | No |
| Ban Kevin M. | 11/17/2022 | 10,303.00 | 38,219.00 | 34.04 | Buy | No |
| SCHLICHTING NANCY M | 11/16/2022 | 16,570.00 | 5,515.00 | 39.89 | Sell | No |
| Gray Danielle | 10/31/2022 | 1,229.00 | 44,945.00 | 36.26 | Sell | No |
| Mahajan Manmohan | 10/31/2022 | 399.00 | 21,235.00 | 36.26 | Sell | No |
| Mahajan Manmohan | 10/31/2022 | 230.00 | 21,634.00 | 36.26 | Sell | No |
| Mahajan Manmohan | 10/31/2022 | 186.00 | 21,864.00 | 36.26 | Sell | No |
| Ban Kevin M. | 10/31/2022 | 261.00 | 27,607.00 | 36.26 | Sell | No |
| Ban Kevin M. | 10/31/2022 | 388.00 | 27,868.00 | 36.26 | Sell | No |
| Pessina Stefano | 10/31/2022 | 4,509.00 | 827,417.00 | 36.26 | Sell | No |
| Barra Ornella | 10/31/2022 | 3,285.00 | 320,924.00 | 36.26 | Sell | No |
| May Holly | 10/31/2022 | 957.00 | 38,611.00 | 36.26 | Sell | No |
| Brown Tracey D | 10/31/2022 | 956.00 | 37,046.00 | 36.26 | Sell | No |
| BREWER ROSALIND G | 10/31/2022 | 9,326.00 | 377,005.00 | 36.26 | Sell | No |
| Kehoe James | 10/31/2022 | 3,617.00 | 251,256.00 | 36.26 | Sell | No |
| Kehoe James | 10/31/2022 | 4,457.00 | 254,873.00 | 36.26 | Sell | No |
| Kehoe James | 10/31/2022 | 3,604.00 | 259,330.00 | 36.26 | Sell | No |
| Gray Danielle | 10/31/2022 | 33,644.00 | 46,174.00 | n/a | Buy | No |
| Mahajan Manmohan | 10/31/2022 | 9,705.00 | 22,050.00 | n/a | Buy | No |
| DRISCOLL JOHN PATRICK | 10/31/2022 | 51,760.00 | 51,760.00 | n/a | Buy | No |
| Ban Kevin M. | 10/31/2022 | 23,292.00 | 28,256.00 | n/a | Buy | No |
| SCHLICHTING NANCY M | 10/31/2022 | 5,515.00 | 22,085.00 | n/a | Buy | No |
| Barra Ornella | 10/31/2022 | 58,230.00 | 324,209.00 | n/a | Buy | No |
| May Holly | 10/31/2022 | 29,762.00 | 39,568.00 | n/a | Buy | No |
Walgreens Boots Alliance Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2022 | Walgreens Boots Alliance Inc | 1.91 | 5.45 | USD |
| 2021 | Walgreens Boots Alliance Inc | 1.88 | 3.70 | USD |
| 2020 | Walgreens Boots Alliance Inc | 1.84 | 4.84 | USD |
| 2019 | Walgreens Boots Alliance Inc | 1.78 | 3.47 | USD |
| 2018 | Walgreens Boots Alliance Inc | 1.64 | 2.39 | USD |
| 2017 | Walgreens Boots Alliance Inc | 1.52 | 1.87 | USD |
| 2016 | Walgreens Boots Alliance Inc | 1.46 | 1.80 | USD |
| 2015 | Walgreens Boots Alliance Inc | 1.37 | 1.59 | USD |
| 2014 | Walgreens Boots Alliance Inc | 1.29 | 2.12 | USD |
| 2014 | Walgreens Boots Alliance Inc | 1.28 | 2.12 | USD |
| 2013 | Walgreens Boots Alliance Inc | 1.14 | 2.37 | USD |
| 2012 | Walgreens Boots Alliance Inc | 1.00 | 2.80 | USD |
| 2012 | Walgreens Boots Alliance Inc | 0.95 | 2.66 | USD |
| 2011 | Walgreens Boots Alliance Inc | 0.80 | 2.27 | USD |
| 2011 | Walgreens Boots Alliance Inc | 0.75 | 2.13 | USD |
| 2010 | Walgreens Boots Alliance Inc | 0.59 | 2.19 | USD |
| 2010 | Walgreens Boots Alliance Inc | 0.63 | 2.33 | USD |
| 2009 | Walgreens Boots Alliance Inc | 0.50 | 1.48 | USD |
| 2009 | Walgreens Boots Alliance Inc | 0.48 | 1.42 | USD |
| 2008 | Walgreens Boots Alliance Inc | 0.40 | 1.10 | USD |
| 2007 | Walgreens Boots Alliance Inc | 0.33 | 0.73 | USD |
| 2006 | Walgreens Boots Alliance Inc | 0.27 | 0.55 | USD |
| 2005 | Walgreens Boots Alliance Inc | 0.22 | 0.47 | USD |
| 2004 | Walgreens Boots Alliance Inc | 0.18 | 0.49 | USD |
| 2003 | Walgreens Boots Alliance Inc | 0.16 | 0.49 | USD |
| 2002 | Walgreens Boots Alliance Inc | 0.15 | 0.43 | USD |
| 2001 | Walgreens Boots Alliance Inc | 0.14 | 0.41 | USD |
| 2000 | Walgreens Boots Alliance Inc | 0.14 | 0.43 | USD |
| 1999 | Walgreens Boots Alliance Inc | 0.13 | 0.57 | USD |
*Yield of the Respective Date
Walgreens Boots Alliance Inc Calendar
| Event | Estimate | Info | Date |
|---|---|---|---|
| Earnings Report | 1.122 USD | Q2 2023 Earnings Release | 03/28/2023 |
| Press Conference | - | 03/28/2023 | |
| Earnings Report | - | Q4 2023 Earnings Release | 10/12/2023 |
| Earnings Report | - | Q1 2024 Earnings Release | 01/04/2024 |
| Earnings Report | - | Q2 2024 Earnings Release | 03/27/2024 |
Walgreens Boots Alliance Inc Past Events
| Event | Actual EPS | Info | Date |
|---|---|---|---|
| Annual General Meeting | - | Annual General Meeting | 01/26/2023 |
| Earnings Report | 1.160 USD | Q1 2023 Earnings Release | 01/05/2023 |
| Press Conference | - | - | 01/05/2023 |
| Press Conference | - | - | 10/13/2022 |
| Press Conference | - | - | 06/30/2022 |
| Press Conference | - | - | 03/31/2022 |
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1901 and is headquartered in Deerfield, IL.
Moody’s Daily Credit Risk Score
Walgreens Boots Alliance Shareholder
| Owner | in % |
|---|---|
| Freefloat | 82.71 |
| Stefano Pessina | 16.91 |
| The Vanguard Group, Inc. | 6.87 |
| Vanguard Group, Inc. (Subfiler) | 6.77 |
| State Street Corp. | 6.66 |
| BlackRock Fund Advisors | 2.87 |
| Vanguard Total Stock Market Index Fund | 2.47 |
| Capital Research & Management Co. (World Investors) | 2.42 |
| Vanguard 500 Index Fund | 1.93 |
| BlackRock Institutional Trust Co. NA | 1.82 |
| Geode Capital Management LLC | 1.55 |
| Invesco Capital Management LLC | 1.37 |
| SPDR S&P Dividend ETF | 1.36 |
| Invesco QQQ Trust | 1.31 |
| Fidelity Management & Research Co. LLC | 1.28 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Walgreens Boots Alliance Management
| Name | Job |
|---|---|
| Manmohan Mahajan | Chief Accounting Officer, SVP & Global Controller |
| Tracey D. Brown | Chief Customer Officer |
| Rosalind Gates Brewer | Chief Executive Officer & Director |
| Hsiao Wang | Chief Information Officer & Senior Vice President |
| Vish Sankaran | Chief Innovation Officer |
| Linh Peters | Chief Marketing Officer & Senior Vice President |
| Luke Rauch | Chief Merchandising Officer & Senior VP |
| Ornella Barra | Chief Operating Officer-International |
| Jim Townsend | Chief Procurement Officer |
| Bala Visalatha | Chief Product Officer & Senior Vice President |
| Mike Maresca | Chief Technology Officer |
| Anita M. Allemand | Chief Transformation & Integration Officer |
| Stefano Pessina | Executive Chairman |
| Carlos W. Cubia | Global Chief Diversity Officer & Senior VP |
| James Kehoe | Global Chief Financial Officer & Executive VP |
| Holly May | Global Chief Human Resources Officer & EVP |
| Danielle C. Gray | Global Chief Legal Officer & Executive VP |
| Kevin M. Ban | Global Chief Medical Officer & Executive VP |
| Omorlie Harris | Global Treasurer & Senior Vice President |
| Tiffany Kanaga | Head-Investor Relations |
| Nancy M. Schlichting | Independent Director |
| Inderpal S. Bhandari | Independent Director |
| Janice May Babiak | Independent Director |
| John Anthony Lederer | Independent Director |
| Bryan C. Hanson | Independent Director |
| Dominic Patrick Murphy | Independent Director |
| Valerie B. Jarrett | Independent Director |
| Ginger L. Graham | Lead Independent Director |
| John Patrick Driscoll | President & Executive VP-US Healthcare |
| Juan Guerra | SVP & Managing Director-International Wholesale |
| Joseph B. Amsbary | Secretary & Senior Vice President |
| Anas Al-Hamwi | Senior Director-Safety & Injury Management |
| Roger Phillips | Vice President-Global Mergers & Acquisitions |